colestipol and Coronary Disease
colestipol has been researched along with Coronary Disease in 45 studies
Research
Studies (45)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (55.56) | 18.7374 |
1990's | 15 (33.33) | 18.2507 |
2000's | 5 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lucas, BD | 1 |
Stamler, J | 2 |
Glueck, CJ | 1 |
Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A | 1 |
Kuo, PT | 1 |
Buchwald, H; Fitch, L; Moore, RB | 1 |
Greten, H; Klose, G | 1 |
Kostis, JB; Kuo, PT; Moreyra, AE | 1 |
Esente, P; Gensini, G; Nash, DT | 1 |
Untereker, WJ | 1 |
Kolb, S; Sailer, D | 1 |
Hayes, JA; Kostis, JB; Kuo, PT; Moreyra, AE | 1 |
Azen, SP; LaBree, L; Lapuerta, P | 1 |
Ginsberg, HN | 1 |
Albers, JJ; Brown, BG; Hillger, L; Poulin, D; Zhao, XQ | 1 |
Albers, JJ; Brown, BG; Dowdy, A; Fisher, LD; Hillger, LA; Sniderman, AD; Stewart, BF; Zhao, XQ | 1 |
Hathaway, SC; Paat, JJ; Paterson, RW; Steele, GH; Wong, JG | 1 |
Albers, JJ; Bisson, B; Brown, BG; Fisher, L; Hillger, L; Sacco, D; Zhao, XQ | 1 |
Coates, PM; Cortner, JA; Jarvik, GP; Liacouras, CA | 1 |
Hiatt, J; Schectman, G | 1 |
Bambauer, R; Müller, UA; Schiel, R | 1 |
Avery, BR | 1 |
Albers, JJ; Brown, BG; Brunzell, JD; Davis, JW; Maher, VM; Poulin, D; Rocha, A; Zambon, A | 1 |
Oster, G; Thompson, D | 1 |
Faulkner, MA; Hilleman, DE; Lucas, BD; Wadibia, EC | 1 |
Brown, BG; Brunzell, JD; Deeb, SS; Hokanson, JE; Zambon, A | 1 |
Susekov, AV | 1 |
Goldbourt, U; Graff, E; Koren-Morag, N; Tanne, D | 1 |
Hayase, K; Kostis, JB; Kuo, PT; Moreyra, AE | 1 |
Grundy, SM | 1 |
Stone, NJ | 1 |
Dorr, AE; Gundersen, K; Martin, WB; Schneider, JC; Spencer, TW | 1 |
Blankenhorn, DH; Sanmarco, ME | 1 |
Baggio, G; Baiocchi, MR; Balestrieri, P; Briani, G; Crepaldi, G; Fellin, R | 1 |
Schon, P | 1 |
Albers, JJ; Bisson, BD; Brown, G; Dodge, HT; Fisher, LD; Fitzpatrick, VF; Kaplan, C; Lin, JT; Schaefer, SM; Zhao, XQ | 1 |
Potts, JF; Setness, PA | 1 |
Anding, RH; Lueg, MC | 1 |
Eisenberg, JM; Kinosian, BP | 1 |
Naito, HK | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Kostis, JB; Kuo, PT; Moreyra, AE; Wilson, AC | 1 |
Hüppe, R; Kohlmeier, M; Schlierf, G; Schmidt-Gayk, H; Vogel, G; Vuilleumier, JP | 1 |
Reviews
10 review(s) available for colestipol and Coronary Disease
Article | Year |
---|---|
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin | 1995 |
Impact of intensive lipid modulation on angiographically defined coronary disease: clinical implications.
Topics: Angiography; Clinical Trials as Topic; Colestipol; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lovastatin; Niacin; Random Allocation | 1994 |
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.
Topics: Adolescent; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoproteins, VLDL; Liver; Male; Multigene Family; Niacin; Phenotype; Polymorphism, Genetic; Triglycerides | 1993 |
Use of niacin, statins, and resins in patients with combined hyperlipidemia.
Topics: Anticholesteremic Agents; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Colestipol; Coronary Disease; Drug Therapy, Combination; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lovastatin; Niacin; Risk Factors; Triglycerides | 1998 |
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.
Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome | 1992 |
[Substantiation of increasing doses of statins in clinical practice].
Topics: Adult; Aged; Angiography; Animals; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Clinical Trials as Topic; Colestipol; Coronary Disease; Dogs; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lovastatin; Male; Meta-Analysis as Topic; Middle Aged; Primates; Prospective Studies; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Time Factors | 2001 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides | 1977 |
Reducing cardiac deaths with hypolipidemic drugs.
Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol | 1987 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological | 1985 |
Trials
15 trial(s) available for colestipol and Coronary Disease
Article | Year |
---|---|
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
Overview of randomized clinical trials of lipid intervention for atherosclerotic cardiovascular disease.
Topics: Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Fatty Acids, Unsaturated; Glycine max; Humans; Hypolipidemic Agents; Lipids; Nicotinic Acids; Oils; Random Allocation; Risk; Zea mays | 1982 |
Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease. Observations from the FATS Trial. Familial Atherosclerosis Treatment Study.
Topics: Adult; Colestipol; Coronary Disease; Diet, Fat-Restricted; Humans; Lovastatin; Male; Middle Aged; Niacin | 1995 |
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Niacin; Treatment Outcome | 1994 |
Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B.
Topics: Adult; Apolipoproteins B; Colestipol; Coronary Disease; Coronary Vessels; Double-Blind Method; Exercise Test; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Radiography | 1993 |
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life | 1995 |
Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial.
Topics: Aged; Cholesterol; Colestipol; Coronary Disease; Counseling; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Myocardial Revascularization; Patient Compliance; Pharmacists; Time Factors; Treatment Outcome; Triglycerides | 2000 |
Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment.
Topics: Analysis of Variance; Cholesterol, HDL; Colestipol; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Genotype; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Liver; Lovastatin; Male; Middle Aged; Niacin; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Promoter Regions, Genetic; Regression Analysis | 2001 |
Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry.
Topics: Adult; Aged; Bezafibrate; Brain Ischemia; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Disease; Follow-Up Studies; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Lovastatin; Middle Aged; Multivariate Analysis; Odds Ratio; Registries; Risk Factors; Survival Analysis; Time Factors | 2002 |
Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis; Cholesterol; Colestipol; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Drug Evaluation; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Placebos; Polyamines; Radiography; Triglycerides; Xanthomatosis | 1979 |
Cholesterol, colestipol and coronary heart disease.
Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Disease; Evaluation Studies as Topic; Female; Humans; Male; Polyamines; Research Design | 1978 |
Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.
Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Polyamines | 1978 |
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Disease; Diet; Double-Blind Method; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Multivariate Analysis; Niacin | 1990 |
Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Colestipol; Combined Modality Therapy; Coronary Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Phenols; Polyamines; Probucol; Triglycerides | 1986 |
Review of primary prevention trials of coronary heart disease.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological | 1985 |
Other Studies
21 other study(ies) available for colestipol and Coronary Disease
Article | Year |
---|---|
Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.
Topics: Colestipol; Coronary Artery Bypass; Coronary Disease; Humans; Hypolipidemic Agents; Lovastatin; Patient Compliance; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides | 1983 |
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines | 1983 |
Treating hyperlipidemia to provide salutary effect on coronary artery disease.
Topics: Arteriosclerosis; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Lipoproteins, LDL | 1984 |
[Lipid lowering treatment and regression of arteriosclerosis (author's transl)].
Topics: Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Clofibrate; Colestipol; Coronary Disease; Haplorhini; Humans; Nicotinic Acids | 1980 |
Protection of myocardium by the compensatory mechanism of coronary collaterals after total occlusion of major coronary arteries shown in patients with familial hypercholesterolemia.
Topics: Adult; Arterial Occlusive Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Colestipol; Coronary Circulation; Coronary Disease; Electrocardiography; Female; Heart; Heart Function Tests; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Niacin; Nicotinic Acids; Radiography; Radionuclide Imaging | 1982 |
Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
Topics: Cholesterol; Colestipol; Coronary Angiography; Coronary Disease; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Polyamines; Risk; Triglycerides | 1982 |
Treatment of hypercholesterolemia. Can it retard atherogenesis?
Topics: Cholesterol; Colestipol; Coronary Angiography; Coronary Disease; Humans; Hypercholesterolemia; Polyamines; Risk | 1982 |
[Treatment of coronary heart disease with diet and lipid-reducing agents].
Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk | 1982 |
Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
Topics: Adult; Angiography; Cholesterol; Cholesterol, Dietary; Colestipol; Coronary Angiography; Coronary Disease; Coronary Vessels; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Nicotinic Acids; Polyamines; Triglycerides | 1981 |
Use of neural networks in predicting the risk of coronary artery disease.
Topics: Adult; Cholesterol; Colestipol; Coronary Artery Disease; Coronary Disease; Diet, Fat-Restricted; Follow-Up Studies; Forecasting; Humans; Lipids; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risk Factors | 1995 |
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals.
Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Colestipol; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Niacin; Peripheral Vascular Diseases; Retrospective Studies; Treatment Outcome; Triglycerides | 1996 |
Treatment of the patient with primary familial heterozygous hypercholesterolemia.
Topics: Aged; Colestipol; Coronary Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Exercise; Female; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Niacin; Patient Compliance; Weight Loss | 1995 |
Angiography for study of lipid-lowering therapy.
Topics: Colestipol; Coronary Angiography; Coronary Disease; Drug Evaluation; Humans; Hyperlipidemias; Patient Dropouts; Polyamines; Risk; Technology, Radiologic | 1979 |
[Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Topics: Adult; Angina Pectoris; Cholesterol; Colestipol; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Polyamines; Triglycerides; Xanthomatosis | 1975 |
Bile acid sequestrants and cholesterol.
Topics: Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Polyamines | 1990 |
Elevated cholesterol levels. How to individualize treatment.
Topics: Adult; Behavior Therapy; Cholesterol, Dietary; Colestipol; Coronary Disease; Exercise; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Risk Factors; Smoking; Wine | 1990 |
Hypercholesterolemia: new values, new strategies.
Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin | 1986 |
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking | 1988 |
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors | 1988 |
[Long-term therapy of familial hypercholesterolemia in young patients with colestipol: availability of minerals and vitamins].
Topics: Adolescent; Adult; Blood Glucose; Calcium; Child; Child, Preschool; Chlorides; Colestipol; Coronary Disease; Female; Humans; Hyperlipoproteinemia Type II; Iron; Lipids; Long-Term Care; Male; Minerals; Parathyroid Hormone; Phosphates; Polyamines; Potassium; Sodium; Vitamins | 1985 |